Conference Call with Syngene International Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals company Syngene International announced Q2FY25 results Revenue from operations increased sequentially by 13% QoQ to Rs 891 crore in Q2FY25, change -2% YoY compared to Rs 910 crore during Q2FY24. H1FY25 revenue was broadly flat, in line with our guidance, at Rs 1,681 crore change -2% YoY compared to Rs 1718 crore during H1FY24. EBITDA: Rs 261 crore compared to Rs 276 crore during Q2FY24 change -5%. PAT: Rs 106 crore compared to Rs 122 crore during Q2FY24 change -13%. Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International, said: “Performance in the second quarter and first half of the year was broadly flat, in line with our expectations. I am pleased with the early positive signs of recovery in Discovery Services, largely driven by collaborations on pilot projects with large and mid-sized biopharma clients looking for alternatives to China to rebalance their supply chains. I am also encouraged to see healthy interest from clients in biologics. We have proven capabilities in biologics and additional manufacturing capacity coming online in the second half of the year. With a strong third quarter already underway, we expect to see a positive change in revenue trajectory in the third quarter and remain on track to deliver within our guidance range for the full year.” Sibaji Biswas, Executive Director and Chief Financial Officer, Syngene International said: “With improving sequential revenues, our operating EBITDA margin came in at 27% for the quarter compared to 22% in the first quarter and broadly within range year-on-year. With recent investments in the research and CDMO businesses, we are in a good position to leverage opportunities to drive medium to long-term growth. The Company maintains a robust balance sheet with strong net cash position, enabling us to invest in strategic areas including digitization, commercial capabilities and new technology to support growth.” Result PDF